BioDuro will provide integrated research services in the areas of discovery chemistry, discovery biology, ADMET, and DMPK services, to help enhance internal drug discovery and shorten development timelines.
Lena Martensson, director of strategic planning and business development at AstraZeneca, said: “After a successful collaboration involving discovery chemistry, ADMET, and DMPK, AstraZeneca has expanded its collaboration with BioDuro to leverage the strengths of its team to help develop new therapeutics.”